CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma ：A Multicenter, Real-World Clinical Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06785584
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:57.917231+00:00
Published At: 2025-01-21T00:00:00+00:00
Record Updated At: 2025-01-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["ALK-positive Advanced NSCLC", "ALK-positive Non-small Cell Lung Cancer (NSCLC)", "MPR", "Neoadjuvant Therapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-01-21"
protocolSection.identificationModule.nctId: "NCT06785584"
protocolSection.identificationModule.officialTitle: "Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operable) ALK-Positive Lung Adenocarcinoma \uff1aA Multicenter, Real-World Clinical Study"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.